Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model
- PMID: 23817738
- PMCID: PMC6903904
- DOI: 10.3892/ijo.2013.1998
Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model
Abstract
Approximately half of all cancer patients present with cachexia, a condition in which disease-associated metabolic changes lead to a severe loss of skeletal muscle mass. Working toward an integrated and mechanistic view of cancer cachexia, we investigated the hypothesis that cancer promotes mitochondrial uncoupling in skeletal muscle. We subjected mice to in vivo phosphorous-31 nuclear magnetic resonance (31P NMR) spectroscopy and subjected murine skeletal muscle samples to gas chromatography/mass spectrometry (GC/MS). The mice used in both experiments were Lewis lung carcinoma models of cancer cachexia. A novel 'fragmented mass isotopomer' approach was used in our dynamic analysis of 13C mass isotopomer data. Our 31P NMR and GC/MS results indicated that the adenosine triphosphate (ATP) synthesis rate and tricarboxylic acid (TCA) cycle flux were reduced by 49% and 22%, respectively, in the cancer-bearing mice (p<0.008; t-test vs. controls). The ratio of ATP synthesis rate to the TCA cycle flux (an index of mitochondrial coupling) was reduced by 32% in the cancer-bearing mice (p=0.036; t-test vs. controls). Genomic analysis revealed aberrant expression levels for key regulatory genes and transmission electron microscopy (TEM) revealed ultrastructural abnormalities in the muscle fiber, consistent with the presence of abnormal, giant mitochondria. Taken together, these data suggest that mitochondrial uncoupling occurs in cancer cachexia and thus point to the mitochondria as a potential pharmaceutical target for the treatment of cachexia. These findings may prove relevant to elucidating the mechanisms underlying skeletal muscle wasting observed in other chronic diseases, as well as in aging.
Figures
Similar articles
-
Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.Int J Mol Med. 2011 Jan;27(1):15-24. doi: 10.3892/ijmm.2010.557. Epub 2010 Nov 10. Int J Mol Med. 2011. PMID: 21069263 Free PMC article.
-
Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P nuclear magnetic resonance and electron paramagnetic resonance spectroscopy.FASEB J. 2013 Jun;27(6):2521-30. doi: 10.1096/fj.12-220764. Epub 2013 Mar 12. FASEB J. 2013. PMID: 23482635 Free PMC article.
-
Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):124-137. doi: 10.1002/jcsm.13391. Epub 2023 Dec 7. J Cachexia Sarcopenia Muscle. 2024. PMID: 38062911 Free PMC article.
-
Muscle wasting in cancer: the role of mitochondria.Curr Opin Clin Nutr Metab Care. 2015 May;18(3):221-5. doi: 10.1097/MCO.0000000000000164. Curr Opin Clin Nutr Metab Care. 2015. PMID: 25769061 Review.
-
Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.Curr Opin Clin Nutr Metab Care. 2015 May;18(3):226-33. doi: 10.1097/MCO.0000000000000161. Curr Opin Clin Nutr Metab Care. 2015. PMID: 25783794 Review.
Cited by
-
Unveiling the Role of the Proton Gateway, Uncoupling Proteins (UCPs), in Cancer Cachexia.Cancers (Basel). 2023 Feb 23;15(5):1407. doi: 10.3390/cancers15051407. Cancers (Basel). 2023. PMID: 36900198 Free PMC article. Review.
-
Impact of cancer cachexia on respiratory muscle function and the therapeutic potential of exercise.J Physiol. 2022 Dec;600(23):4979-5004. doi: 10.1113/JP283569. Epub 2022 Nov 1. J Physiol. 2022. PMID: 36251564 Free PMC article. Review.
-
PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice.Appl Physiol Nutr Metab. 2022 Sep 1;47(9):933-948. doi: 10.1139/apnm-2022-0086. Epub 2022 Jun 14. Appl Physiol Nutr Metab. 2022. PMID: 35700525 Free PMC article.
-
Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers.Front Cell Dev Biol. 2021 Sep 14;9:719643. doi: 10.3389/fcell.2021.719643. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34595171 Free PMC article. Review.
-
Development and progression of cancer cachexia: Perspectives from bench to bedside.Sports Med Health Sci. 2020 Dec;2(4):177-185. doi: 10.1016/j.smhs.2020.10.003. Epub 2020 Dec 3. Sports Med Health Sci. 2020. PMID: 34447946 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
